The Role of Pembrolyzum in the Treatment of Endometrial Cancer

Rama's Nausifis Gander, a maginoclogic oncologist at the University of California San Diego Morris Cancer Center, and I'm an associate professor of gynecologic oncology. NRGGY018 was a prospective randomized phase three placebo-controlled and blinded clinical trial that was designed to help us answer whether or not Pembrolyzum app would benefit patients with advanced age or recurrent endometrial cancer.